Guangxi LiuYao Group Co (SHSE:603368) Research & Development: ¥42 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603368 Guangxi LiuYao Group Co Ltd SHSE:603368
84 GF Score
Price ¥15.54
GF Value ¥18.26
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Guangxi LiuYao Group Co Research & Development?

Guangxi LiuYao Group Co SHSE:603368 +0.19% 84 Research & Development is ¥42 Mil as of Mar. 2026. GuruFocus rates SHSE:603368 with a GF Score™ of 84/100 and a GF Value™ of ¥18.26 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Guangxi LiuYao Group Co's Research & Development for the three months ended in Mar. 2026 was ¥13 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥42 Mil.

Guangxi LiuYao Group Co  (SHSE:603368) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Guangxi LiuYao Group Co Research & Development Related Terms

Guangxi LiuYao Group Co Research & Development Historical Data

* Premium members only.

The historical data trend for Guangxi LiuYao Group Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangxi LiuYao Group Co Research & Development Chart

Guangxi LiuYao Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.61 25.80 36.64 39.63 38.47

Guangxi LiuYao Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.28 8.40 12.82 7.99 12.54
SHSE:603368
84GF Score
Guangxi LiuYao Group Co Ltd SHSE:603368
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangxi LiuYao Group Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥42 Mil mean?
Guangxi LiuYao Group Co (SHSE:603368) has a Research & Development of ¥42 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Guangxi LiuYao Group Co and its competitors.
Is Guangxi LiuYao Group Co's Research & Development too high?
Guangxi LiuYao Group Co's current Research & Development is ¥42 Mil. Overall, Guangxi LiuYao Group Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangxi LiuYao Group Co's Research & Development compare to MCK and COR?
Guangxi LiuYao Group Co's Research & Development of ¥42 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Guangxi LiuYao Group Co and its competitors. Guangxi LiuYao Group Co's current Research & Development is ¥42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangxi LiuYao Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangxi LiuYao Group Co (SHSE:603368) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥18.26, compared to a current price of ¥15.54 — trading 14.9% below its estimated fair value. The current Research & Development is ¥42 Mil. Guangxi LiuYao Group Co's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Guangxi LiuYao Group Co (SHSE:603368), the current Research & Development is ¥42 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangxi LiuYao Group Co (SHSE:603368) Overvalued in 2026?

Based on GuruFocus' analysis, Guangxi LiuYao Group Co stock appears to be undervalued. The current stock price of ¥15.54 is trading 14.9% below its estimated GF Value™ of ¥18.26. GuruFocus considers Guangxi LiuYao Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:603368:

  • Research & Development: ¥42 Mil
  • GF Value™: ¥18.26 vs. price of ¥15.54 (14.9% below fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603368 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangxi LiuYao Group Co Business Description

Address No. 68 Guantang Avenue, Guangxi Zhuang Autonomous Region, Liuzhou, CHN, 545000
Guangxi LiuYao Group Co Ltd is a regional pharmaceutical distribution enterprise focusing on hospital sales and developing both retail pharmacies and third terminals.
84GF Score

Get the complete analysis for SHSE:603368

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.54
Price
¥18.26
GF Value